Pfizer shares surge on positive impact of their mRNA Covid-19 vaccine — partnered with BioNTech — in an early-stage study
Pfizer and their partners at the mRNA specialist BioNTech have published the first glimpse of biomarker data from an early …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
